Venture capital firms are crucial for biotech startups, providing financial and operational support. Notables in the industry include Third Rock Ventures, Sofinnova and OrbiMed, among others. Over time, many pharma and biotech companies have also started their own venture capital funds to identify and invest in potential acquisitions. This article explores the work of 10 significant pharma and biotech venture capital arms, including AbbVie Ventures, Astellas Venture Management, JJDC, Leaps by Bayer, M Ventures, Novartis Venture Fund, Novo Holdings, Pfizer Ventures, Regeneron Ventures, and Sanofi Ventures.
StockWatch: Parabilis Medicines Makes Wall Street History with $770.5M IPO
In what’s shaping up to be a historic year for biotech initial public offerings, Parabilis Medicines (Nasdaq: PBLS) made its mark on Wall Street this past week by
